<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230105057054N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-03-28</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of MIND diet and propolis supplement on metabolic syndrome and cognitive function</public_title>
      <acronym>MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay diet)</acronym>
      <scientific_title>Comparison of the effects of MIND diet and propolis supplementation on metabolic syndrome indices and cognitive function and its areas in people with metabolic syndrome. Randomized controlled clinical trial.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-05-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>84</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68419</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Factorial, Purpose: Treatment, Randomization description: Random assignment to intervention and control groups. samples will be allocated to the intervention and control groups using a randomized block design. The randomization unit is the individual that will be used from the table of random numbers.
Eligible people visiting the clinic enter in 28 blocks of three. The first 3 eligible subjects are placed in the first block, the second 3 in the second block, and the 28th 3 in the 28th block. For all three intervention and control groups codes A, B, and C are named. The subjects of each block are based on the table of random numbers, so that if the random number is 1-3, treatment A, if it is 4-6, treatment B, and if it is 7-9, treatment C (Random numbers generated by the computer can also be used for this purpose). Therefore, based on the received random number, the first person in the block is assigned to the treatment code corresponding to the random number. This process will continue until 28 blocks are completed.</study_design>
      <phase>3</phase>
      <hc_freetext>Condition 1: metabolic syndrome. Condition 2: cognitive function.</hc_freetext>
      <i_freetext>Intervention 1: First intervention group: MIND diet and placebo. The counseling plan for the intervention diet group will include instructions on what foods to include in the diet, the paths to provide these foods. The dietary regimen being employed in this study is the MIND diet, as outlined by Morris et al in its expanded form. Participants in the MIND diet group will receive instructions to modify their dietary content, emphasizing natural and plant-based foods and consuming berries and green leafy vegetables, whole grains, fish, nuts, and olive oil and with restricted consume of animal’s food and high saturated fat is recommended. According to Islamic customs and culture, the people of Iran are bound not to consume alcoholic beverages, so, we persuade our patients to use grapes, grape juice, and raisins for correcting. For each person, the MIND diet will be provided specifically for seven days a week along with counseling for at least 30 minutes, and continue for 3 monthsو and people will be asked to visit the relevant center for three days (days 7, 45, and 80 of the study). and the minimum time for each person in each meeting will be 15 minutes for counseling and checking compliance with the diet. In addition, routine dietary advice will be used, which will include verbal and written general data about healthy food selections according to the healthy food plate (50-60% carbohydrates, 5-20% protein, and 30% fat). All participants will get acquainted with the principles of food recommendations, which are as follows: Eat slowly and chew your food completely and with pleasure. Instead of frying foods, use steamed, boiled, and grilled foods. take off any excess fat and skin from your chicken or meat before cooking. use whole-meal bread and mixed oats and rice instead of simple rice and pasta. refrain from removing any meals. Eat frequent but small meals. Try to limit your intake of sugary and fatty foods. This combination is more similar to the food pattern of Iranians. Microcrystalline cellulose placebo will also be used in this group, the drug and placebo will be completely similar which will be prepared in the Department of Pharmacology of Mashhad University of Medical Sciences and none of the participants and researchers will know about them until the end of the study. Intervention 2: Second intervention group: MIND diet and propolis supplementation. The counseling plan for the intervention diet group will include instructions on what foods to include in the diet, the paths to provide these foods. The dietary regimen being employed in this study is the MIND diet, as outlined by Morris et al in its expanded form. Participants in the MIND diet group will receive instructions to modify their dietary content, emphasizing natural and plant-based foods and consuming berries and green leafy vegetables, whole grains, fish, nuts, and olive oil and with restricted consume of animal’s food and high saturated fat is recommended. According to Islamic customs and culture, the people of Iran are bound not to consume alcoholic beverages, so, we persuade our patients to use grapes, grape juice, and raisins for correcting. For each person, the MIND diet will be provided specifically for seven days a week along with counseling for at least 30 minutes, and continue for 3 monthsو and people will be asked to visit the relevant center for three days (days 7, 45, and 80 of the study). and the minimum time for each person in each meeting will be 15 minutes for counseling and checking compliance with the diet. In addition, routine dietary advice will be used, which will include verbal and written general data about healthy food selections according to the healthy food plate (50-60% carbohydrates, 5-20% protein, and 30% fat). All participants will get acquainted with the principles of food recommendations, which are as follows: Eat slowly and chew your food completely and with pleasure. Instead of frying foods, use steamed, boiled, and grilled foods. take off any excess fat and skin from your chicken or meat before cooking. use whole-meal bread and mixed oats and rice instead of simple rice and pasta. refrain from removing any meals. Eat frequent but small meals. Try to limit your intake of sugary and fatty foods. This combination is more similar to the food pattern of Iranians. Also it will be recommended to take a propolis supplement which will be prepared in the Department of Pharmacology of Mashhad University of Medical Sciences (Take 450 mg twice daily before lunch and dinner) for 3 months. Intervention 3: Control group: microcrystalline cellulose placebo. For these individuals, routine dietary advice will be used, which will include verbal and written general data about to ensure your diet is balanced, aim for healthy food choices that follow the guidelines of the healthy food plate. This means consuming around 50-60% carbohydrates, 5-20% protein, and 30% fat. In this case, none of participants will receive food menus and will get acquainted with the principles of food recommendations, as follows:  Eat slowly and chew your food completely and with pleasure. Instead of frying foods, use steamed, boiled, and grilled foods. take off any excess fat and skin from your chicken or meat before cooking. use whole-meal bread and mixed oats and rice instead of simple rice and pasta. refrain from removing any meals. Eat frequent but small meals. Try to limit your intake of sugary and fatty foods. In addition to the usual food recommendations, the microcrystalline cellulose placebo will be used. The drug and the placebo will be completely similar which will be prepared in the Department of Pharmacology of Mashhad University of Medical Sciences and none of the participants and researchers will know about them until the end of the study.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data will be available upon reasonable request from Prof. Zamzam Paknahad

When:
12 months after publication of results

To whom:
Academic users

Conditions:
Academic purposes

Where to obtain:
paknahad@hlth.mui.ac.ir

How to obtain:
Upon receipt of the request, the data will be sent as soon as possible.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Zamzam Paknahad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar jerib</address>
        <city>Isfehan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81746-73461</zip>
        <telephone>+98 31 3792 3166</telephone>
        <email>paknahad@hlth.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Zamzam paknahad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar jerib</address>
        <city>Isfehan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81746-73461</zip>
        <telephone>+98 31 3792 3166</telephone>
        <email>paknahad@hlth.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Participants must provide informed consent prior to engaging in the study
Adults (18-60 years old)
have metabolic syndrome</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Suffering from thyroid diseases, anemia, diabetes, neurological and psychiatric illnesses containing depression, Parkinson's disease, Alzheimer's disease, mental disorders and, a history of severe medical treatment.
Have a stroke or transient ischemic attack in the last 3 months.
Have a history of brain damage, liver and kidney disease, hepatitis C or HIV.
have been diagnosed with cancer in the last five years.
Obese people with a BMI higher than 40</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E88.81</hc_code>
      <hc_code>R41</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Metabolic syndrome</hc_keyword>
      <hc_keyword>Other symptoms and signs involving cognitive functions and awareness</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First intervention group: MIND diet and placebo. The counseling plan for the intervention diet group will include instructions on what foods to include in the diet, the paths to provide these foods. The dietary regimen being employed in this study is the MIND diet, as outlined by Morris et al in its expanded form. Participants in the MIND diet group will receive instructions to modify their dietary content, emphasizing natural and plant-based foods and consuming berries and green leafy vegetables, whole grains, fish, nuts, and olive oil and with restricted consume of animal’s food and high saturated fat is recommended. According to Islamic customs and culture, the people of Iran are bound not to consume alcoholic beverages, so, we persuade our patients to use grapes, grape juice, and raisins for correcting. For each person, the MIND diet will be provided specifically for seven days a week along with counseling for at least 30 minutes, and continue for 3 monthsو and people will be asked to visit the relevant center for three days (days 7, 45, and 80 of the study). and the minimum time for each person in each meeting will be 15 minutes for counseling and checking compliance with the diet. In addition, routine dietary advice will be used, which will include verbal and written general data about healthy food selections according to the healthy food plate (50-60% carbohydrates, 5-20% protein, and 30% fat). All participants will get acquainted with the principles of food recommendations, which are as follows: Eat slowly and chew your food completely and with pleasure. Instead of frying foods, use steamed, boiled, and grilled foods. take off any excess fat and skin from your chicken or meat before cooking. use whole-meal bread and mixed oats and rice instead of simple rice and pasta. refrain from removing any meals. Eat frequent but small meals. Try to limit your intake of sugary and fatty foods. This combination is more similar to the food pattern of Iranians. Microcrystalline cellulose placebo will also be used in this group, the drug and placebo will be completely similar which will be prepared in the Department of Pharmacology of Mashhad University of Medical Sciences and none of the participants and researchers will know about them until the end of the study.</i_keyword>
      <i_keyword>Second intervention group: MIND diet and propolis supplementation. The counseling plan for the intervention diet group will include instructions on what foods to include in the diet, the paths to provide these foods. The dietary regimen being employed in this study is the MIND diet, as outlined by Morris et al in its expanded form. Participants in the MIND diet group will receive instructions to modify their dietary content, emphasizing natural and plant-based foods and consuming berries and green leafy vegetables, whole grains, fish, nuts, and olive oil and with restricted consume of animal’s food and high saturated fat is recommended. According to Islamic customs and culture, the people of Iran are bound not to consume alcoholic beverages, so, we persuade our patients to use grapes, grape juice, and raisins for correcting. For each person, the MIND diet will be provided specifically for seven days a week along with counseling for at least 30 minutes, and continue for 3 monthsو and people will be asked to visit the relevant center for three days (days 7, 45, and 80 of the study). and the minimum time for each person in each meeting will be 15 minutes for counseling and checking compliance with the diet. In addition, routine dietary advice will be used, which will include verbal and written general data about healthy food selections according to the healthy food plate (50-60% carbohydrates, 5-20% protein, and 30% fat). All participants will get acquainted with the principles of food recommendations, which are as follows: Eat slowly and chew your food completely and with pleasure. Instead of frying foods, use steamed, boiled, and grilled foods. take off any excess fat and skin from your chicken or meat before cooking. use whole-meal bread and mixed oats and rice instead of simple rice and pasta. refrain from removing any meals. Eat frequent but small meals. Try to limit your intake of sugary and fatty foods. This combination is more similar to the food pattern of Iranians. Also it will be recommended to take a propolis supplement which will be prepared in the Department of Pharmacology of Mashhad University of Medical Sciences (Take 450 mg twice daily before lunch and dinner) for 3 months.</i_keyword>
      <i_keyword>Control group: microcrystalline cellulose placebo. For these individuals, routine dietary advice will be used, which will include verbal and written general data about to ensure your diet is balanced, aim for healthy food choices that follow the guidelines of the healthy food plate. This means consuming around 50-60% carbohydrates, 5-20% protein, and 30% fat. In this case, none of participants will receive food menus and will get acquainted with the principles of food recommendations, as follows:  Eat slowly and chew your food completely and with pleasure. Instead of frying foods, use steamed, boiled, and grilled foods. take off any excess fat and skin from your chicken or meat before cooking. use whole-meal bread and mixed oats and rice instead of simple rice and pasta. refrain from removing any meals. Eat frequent but small meals. Try to limit your intake of sugary and fatty foods. In addition to the usual food recommendations, the microcrystalline cellulose placebo will be used. The drug and the placebo will be completely similar which will be prepared in the Department of Pharmacology of Mashhad University of Medical Sciences and none of the participants and researchers will know about them until the end of the study.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fasting blood sugar. Timepoint: Before and after study. Method of measurement: blood sample.</prim_outcome>
      <prim_outcome>Triglyceride. Timepoint: Before and after study. Method of measurement: blood sample.</prim_outcome>
      <prim_outcome>High density lipoprotein cholesterol. Timepoint: Before and after study. Method of measurement: blood sample.</prim_outcome>
      <prim_outcome>Blood pressure. Timepoint: Before and after study. Method of measurement: sphygmomanometer.</prim_outcome>
      <prim_outcome>Cognitive function. Timepoint: Before and after study. Method of measurement: Neuropsychiatry Unit Cognitive Assessment.</prim_outcome>
      <prim_outcome>Waist. Timepoint: Before and after study. Method of measurement: inflexible meter.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-02-05</approval_date>
        <contact_name>Ethics Committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Hazar Jerib Street, Isfahan University of Medical Sciences and Health Services Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
